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ABSTRACT 
A 63-year-old woman was diagnosed with ovarian cancer and peritoneal carcinomatosis. The day after paclitaxel 
was administered, an acute myocardial infarction occurred. Emergency coronary angiography revealed a filling 
defect in the left main coronary artery and total occlusion in the distal left anterior descending coronary artery, 
with no luminal irregularity or narrowing. Intravascular ultrasonography showed no significant plaque in the left 
main coronary artery. A thrombophilia work-up was negative, and the patient was treated with tirofiban, clopi-
dogrel, and aspirin. The follow-up coronary angiogram showed that the occlusion of the distal obtuse marginal 
branch and distal left anterior descending artery had cleared. Paclitaxel has been associated with acute myocardial 
infarction. However, the pathogenesis of myocardial infarction associated with paclitaxel is not known. This case 
raises the possibility that paclitaxel can induce coronary artery thrombosis, resulting in myocardial infarction. 
(Korean Circ J 2009;39:124-127) 
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Introduction 
 
It is rare for an acute myocardial infarction (AMI) to 
occur without angiographic evidence of atherosclerosis. 
Possible mechanisms for such an event include coronary 
artery spasm, coronary embolism from an intracardiac 
or paradoxical (venous) source, thrombosis caused by 
hypercoagulable states, and inflammation in response to 
specific infectious agents.
1) Paclitaxel has been associat-
ed with acute myocardial infarction.
2) We report a case 
of coronary artery thrombosis associated with paclitaxel 
in advanced ovarian malignancy.   
 
Case 
 
A 63-year-old woman was diagnosed with ovarian 
cancer and peritoneal carcinomatosis. A large left ovar-
ian mass and omental cake with a large volume of ascites 
were noted on pelvic computed tomography (CT), and 
through positron emission tomography (PET), 
18F-fluor-
odeoxyglucose (
18F-FDG) uptake was noted in the left 
ovarian mass and omental cake. The serum CA-125 level 
was markedly elevated (4,290 U/mL; normal, <35 U/ 
mL). The patient had a history of hypertension, but no 
history of recent infectious disease, drug use, or smok-
ing. Neoadjuvant chemotherapy with a paclitaxel/car-
boplatin regimen was planned. First, paclitaxel was ad-
ministered intravenously over 3 hours at 175 mg/m
2, 
and after 48 hours, the administration of carboplatin 
was planned. 
However, the day after we administered the paclitaxel, 
the patient complained of typical angina. An electro-
cardiogram (ECG) showed ST segment elevation in the 
V2-5 leads (Fig. 1A). The cardiac troponin T and crea-
tine kinase-MB (CK-MB) levels were elevated at 1.03 
ng/mL (normal, <0.01 ng/mL) and 80 U/L (normal, 
<24 U/L), respectively. An echocardiogram demonstrat-
ed mid-anterior, septal, and apical akinesia, consistent 
with infarction in the left anterior descending (LAD) 
territory. 
Emergency coronary angiography revealed a filling 
defect in the left main coronary artery and total occlu-
sion in the distal left anterior descending coronary artery 
with no luminal irregularity or narrowing. We attempted 
to perform a detailed examination of the left main cor-
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onary artery. After we guided the catheter into the left 
main ostium, an additional cine view revealed that the 
filling defect in the left main had disappeared and the 
distal portion of the obtuse marginal branch of the left 
circumflex artery was now totally occluded. Intravas-
cular ultrasonography (IVUS) showed no significant pla-
que burden or atheromatous rupture from the proximal 
left anterior descending artery to the left main coronary 
ostium. We made an unsuccessful attempt with balloon 
angioplasty to restore coronary blood flow (Fig. 2). 
A thrombophilia work-up revealed normal or negative 
values for antithrombin III, protein C, protein S, lupus 
anticoagulant antibody, Factor VIII, anti-phospholipid 
IgG, Factor 5 Leiden, homocysteine, C3, and C4. Treat-
ment with tirofiban, clopidogrel, and aspirin was plann-
ed, and a follow-up electrocardiogram was obtained (Fig. 
1B). Eighteen days after the index procedure, a follow-
up echocardiogram and coronary angiogram were per-
formed. The echocardiogram showed much improve-
ment of the previous akinesia, except at the tip of the 
apex of the left ventricle. The coronary angiogram 
showed that the occlusion of the distal obtuse marginal 
branch and distal left anterior descending artery had 
cleared (Fig. 3). 
The patient is being followed in our outpatient de-
partment and has had no further cardiac symptoms. 
 
Discussion 
 
We present a case of coronary occlusion secondary to 
thrombus formation. An acute myocardial infarction 
(AMI) without angiographic evidence of atherosclerosis 
is uncommon; possible mechanisms include 1) coronary 
artery spasm, 2) coronary embolism from an intracar-
diac or paradoxical (venous) source, 3) thrombosis caused 
by certain hypercoagulable states, and 4) inflammation 
in response to specific infectious agents, such as Chla-
mydia pneumoniae, cytomegalovirus, and Helicobacter 
pylori.
1) Coronary thrombosis may follow blood disorders 
causing hypercoagulability, oral contraceptives or estro-
gen-replacement therapy, endothelial dysfunction, or 
cigarette smoking, as well as an excess of lipoprotein(a) 
[Lp(a)] and type-1 plasminogen activator inhibitor (PAI-
1).
1) Our patient had no history of recent infection, 
drug use, or smoking. Furthermore, there was no specific 
finding in the thrombophilia work-up. In the setting of 
malignancy, there are a few reported cases involving 
myocardial infarctions caused by tumor emboli, direct  
Fig. 1. Initial ECG showed ST segment elevation in the V2-5 leads (A). Follow-up ECG showed normal sinus rhythm without ST-T 
change (B).  
A 
B  
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Fig. 2. Coronary angiogram showing the filling defect in the left main coronary artery (A and B: white arrows) and total occlusion of the 
distal left anterior descending coronary artery (A: black arrows) without any luminal irregularity or narrowing. An additional cine view
showing disappearance of the intraluminal filling defect in the left main coronary artery (C: white arrow) and total occlusion secondary to 
embolization of the thrombus into the obtuse marginal branch of the left circumflex artery (C: black arrow). Intravascular ultrasonography 
showed no significant plaque in the left main coronary artery (D). 
A  B 
C  D 
Fig. 3. Follow-up coronary angiogram showing reopening of the occlusion of the distal obtuse marginal branch (A: black arrow) and 
distal left anterior descending artery (A and B: white arrow). 
A  B  
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malignant infiltration, and non-bacterial thrombotic 
endocarditis (NBTE).
3) However, an extensive search of 
the literature found only one report of in situ coronary 
thrombosis associated with malignancy in the absence 
of other procoagulant conditions.
3) According to a recent 
report, malignancy itself usually does not cause coronary 
artery thrombosis without other hypercoagulable states.
1) 
However, paclitaxel use has been associated with acute 
myocardial infarction.
2)5) In our case, the coronary an-
giogram and IVUS showed a smooth wall without a 
significant stenotic lesion or plaque burden in the left 
main coronary artery. In the follow-up coronary angio-
gram, because the lesion in the culprit vessel disappear-
ed, we presumed that the lesion was not a tumor em-
bolus, but a thrombus. In addition, no intracardiac shunt 
was seen on the echocardiogram, and the regional wall 
motion abnormality of the left ventricle was consistent 
with the coronary territory. Acute myocardial infarction 
can be caused by a coronary thrombus in association 
with a myocardial bridge and slow coronary flow.
6) How-
ever, the coronary angiogram of our case did not show a 
myocardial bridge or slow coronary flow. Except for the 
malignancy, the patient showed no evidence of throm-
bophilia based on the thrombophilia work-up, and as 
mentioned above, malignancy does not usually cause 
coronary artery thrombosis. Therefore, in this case, we 
considered paclitaxel to be the probable cause of the 
myocardial infarction due to spontaneous formation of 
a thrombus in the left main coronary artery. It has been 
seen that paclitaxel can disturb cardiac rhythm and cause 
cardiac ischemia and myocardial infarction.
2)4) Myocar-
dial infarction associated with paclitaxel therapy has 
been reported in some patients.
2)5) In one of these pa-
tients, a 70% lesion with a fresh thrombus in the in-
farct-related artery was documented at autopsy.
2) To 
date, the pathogenesis of myocardial infarction associat-
e d  w it h  p acl itax e l  is  n o t  k n o w n . Ho w e v e r , t h is  cas e  
raises the possibility that paclitaxel can induce coronary 
artery thrombosis and cause myocardial infarction. Ad-
ditionally, we recommend that clinicians take extra care 
in ruling out myocardial infarction if chest pain occurs 
during paclitaxel administration. 
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